Medicine and Health Sciences Commons^™

The Prognostic Significance Of Glucose-6-Phosphate Dehydrogenase As A Biomarker In Head And Neck Squamous Cell Carcinomas Treated With Conventional Chemoradiation, Kenneth H. Barker, Barbara L. Pruetz, Jessica D. Arden, Thomas J. Quinn, George D. Wilson

Posters

INTRODUCTION
The prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with chemoradiation can be predicted using p16 as a surrogate biomarker of Human Papilloma Virus (HPV) status, but a subset of patients continues to do poorly despite a positive or negative p16 status. This project attempted to identify another biomarker, glucose-6-phosphate dehydrogenase (G6PD) as a marker for prognosis in HNSCC patients. Radiation induces oxidative damage to destroy tumor cells, and G6PD is a key enzyme involved in protecting cells from oxidative damage. The goal of this project was to identify a prognostic biomarker that would aid …

Oncolog, Volume 63, Number 08, August 2018, Angie N. Meus, Joe Munch, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• High-Dose Radiation Therapy for Pancreatic Cancer: trial tests whether radiomodulating agent GC4419 can enable higher doses of stereotactic body radiation therapy
• Image-Guided Cordotomy for Cancer Pain: Computed tomography-guided cordotomy relieves cancer-related refractory pain
• Esophageal, Pharyngoesophageal Reconstruction: Advanced surgical techniques restore digestive continuity
• Therapy Preserves Swallowing Function: New trial tests different swallowing therapy regimens for head and neck cancer patients undergoing radiation therapy
• OncoLog Says Farewell

Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Local Consolidative Therapy Plus Immunotherapy or Targeted Agents for NSCLC: Clinical trials explore surgery/radiation plus immune checkpoint or tyrosine kinase inhibitors for metastatic non-small cell lung cancer
• INBRIEF: CAR T Cells Elicit Durable Responses in Large B Cell Lymphoma
• Managing Opioid Use in Cancer Patients: Vigilance and interventions ensure patient safety
• Hepatitis C Virus Linked to Head and Neck Cancers: Association of HCV with extrahepatic cancers has implications for HCV testing, treatment
• HOUSE CALL: Understanding cancer Risk and Risk factors-Your risk factors might affect your need for cancer screening

Oncolog, Volume 63, Number 02, February 2018, Sarah Bronson, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Radiation Therapy for Liver Cancer: Clinical trials expand treatment options for patients with primary liver cancer
• Proton Therapy for Breast Cancer May Avoid Heart Damage: Trial compares cardiotoxicity of proton-and photon-based radiation therapy to the breast/chest wall and lymph nodes
• New targeted Therapies for Leukemia: New treatments target CD123, BCL2 proteins in acute myelogenous leukemia, blastic plasmacytoid dendritic cell neoplasm
• HOUSE CALL: Supportive Care for Cancer Patients- Supportive care treats the whole patient, not just the cancer

Oncolog, Volume 63, Number 01, January 2018, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Immunotherapy for Genitourinary Cancers: Clinical trials explore immune checkpoint inhibitors for bladder, kidney, prostate cancers
• Active Surveillance for Ductal Carcinoma in Situ: COMET trial compares frequent mammography to standard treatment with surgery
• Radiation Plus Chemotherapy for Nasal NK T Cell Lymphoma: Clinical trial may standardize treatment for rare cancer
• HOUSE CALL: Mammography Is Essential for Breast cancer Screening- FDA warns against clinics that advertise screening without mammography
• USEFULRESOURCES: Videoconferences Allow Collaboration in Cancer Prevention, Treatment, Survivorship

Oncolog, Volume 62, Number 09, September 2017, Joe Munch, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Laser Interstitial Thermal Therapy for Spinal Metastases: Laser technique may be alternative to open surgery prior to stereotactic radiation therapy for metastases adjacent to the spinal cord.
• Immunotherapy Plus Targeted Therapy for Anaplastic Thyroid Cancer: Trial combines atezolizumab with targeted or cytotoxic agents for patients with anaplastic or poorly differentiated thyroid cancer.
• A New era in Follicular Lymphoma: Newly approved drugs, clinical trials represent shift from cytotoxic to targeted and immunotherapeutic agents.
• HOUSE CALL: Understanding Clinical Trials- Trials provide access to new cancer treatments
• INBRIEF: Repeat Surgery for Close Margins May Be Unnecessary for DCIS Patients Receiving Radiation Therapy

Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson

OncoLog MD Anderson's Report to Physicians (All issues)

• Immunotherapy for Smoldering Myeloma: Clinical trials test PD-1, DC38 inhibitors to delay progression from premalignant disease to multiple myeloma.
• Malignant Pheochromocytoma and Sympathetic Paraganglioma Research: Studies may expand treatment options for patients with rare neuroendocrine tumors.
• Hypofractionated Partial-Breast Irradiation: Clinical trial tests 10-day external-beam radiation therapy regimen after lumpectomy for patients with early-stage breast cancer.
• HOUSE CALL: Support for Cancer Patients: Patients, caregivers find many types of support from various organizations

Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed

OncoLog MD Anderson's Report to Physicians (All issues)

• Neoadjuvant Immunotherapy for Melanoma: Trial investigates immune checkpoint blockade in patients with respectable stage III or oligometastatic stage IV disease.
• Radiation May Enhance Immunotherapy for Solid Tumors: Clinical Trials combine immune checkpoint inhibitors with radiation therapy against lung cancers, other solid tumors.
• INBRIEF: Nivolumab Plus Azacitidine Shows Promise in Relapsed Acute Myelogenous Leukemia/ Acute Myelogenous Leukemia, Myelodysplastic Syndrome Study Questions Standard Exclusion Criteria for Conventional Trials
• HOUSE CALL: Social Media Groups for Cancer Patients-Twitter chats, online groups for patients, caregivers
• USEFUL RESOURCES: Resources to Aid Referring Physicians

Oncolog, Volume 61, Number 07, July 2016, Bryan Tutt, Sarah Bronson, Laura Russell

OncoLog MD Anderson's Report to Physicians (All issues)

• Improving Rates of Vaccination after Hematopoietic Stem Cell Transplant: Patients who have undergone a hematopoietic stem cell transplant (HSCT) for a hematological cancer usually lose the immunity they had acquired through vaccination. Although guidelines exist for vaccinating immunocompromised transplant recipients, many patients go unvaccinated or do not complete the series of vaccinations. An ongoing initiative at The University of Texas MD Anderson Cancer Center is using a multipronged approach to improve rates of vaccination after HSCT.
• Bone Loss Prevention in Patients with Cancer: Patients undergoing cancer treatment are at an increased risk of fractures because many cancer therapies tend to …

Oncolog, Volume 61, Number 06, June 2016, Jill Deisigne, Joe Munch, Kathryn Hale, B Strubberg

OncoLog MD Anderson's Report to Physicians (All issues)

• Proton Therapy Trials May Provide More Options for Patients with Non-Small Cell Lung Cancer: Proton therapy offers the potential to deliver a higher radiation dose to lung tumors and a lower dose to healthy tissues than does standard radiation therapy. However, the effectiveness of proton therapy has not yet been documented in clinical trials for patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer. Two ongoing trials of proton therapy aim to demonstrate its effectiveness and may change the standard of care for NSCLC.
• Innovative "Basket" Trial Shows Promise of BRAF Inhibition in Various Cancers: …

Oncolog, Volume 61, Number 04, April 2016, Joe Munch, Bryan Tutt, K Werner

OncoLog MD Anderson's Report to Physicians (All issues)

• Aggressive Multimodality Salvage Therapy for Locally Recurrent Rectal Cancer Offers Hope to Patients: For patients with locally recurrent rectal cancer, multimodality salvage therapy presents the only chance for a cure. Such therapy is offered at just a handful of specialized referral institutions, including The University of Texas MD Anderson Cancer Center.
• Rapid Assessment, Clinical Trials Could Improve Outcomes for Anaplastic Thyroid Cancer Patients: Anaplastic thyroid cancer is extremely aggressive-only 20% of patients survive 1 year after their diagnosis-so patients require immediate assessment and treatment. A program at The University of Texas MD Anderson Cancer Center expedites the care of patients …

Oncolog, Volume 61, Number 03, March 2016, Bryan Tutt, Sarah Bronson, Jill Deisigne, K Werner

OncoLog MD Anderson's Report to Physicians (All issues)

• Innovations Decrease Toxic Effects of Radiation Therapy for Mediastinal Tumors from Hematological Malignancies: Anterior mediastinal masses caused by lymphoma or leukemia can be difficult to treat because sensitive tissues in the area are vulnerable to damage from radiation therapy. To treat these tumors while sparing healthy tissue, radiation oncologists at The University of Texas MD Anderson Cancer Center use a combination of advanced technologies and new techniques.
• Transoral Robotic Surgery Enables Less Toxic Treatment of Early Throat Cancers: For decades, many patients with hard-to-reach throat cancers received high-dose radiation and chemotherapy, with their often severe toxic effects, because conventional surgery …

Oncolog, Volume 61, Number 02, February 2016, Joe Munch, Bryan Tutt, C Graber

OncoLog MD Anderson's Report to Physicians (All issues)

• Overcoming Challenges in Cutaneous T Cell Lymphomas: Cutaneous T Cell lymphomas (CTCLs) not only are largely incurable but also make patients miserable with itching, burning skin and unsightly lesions. Because CTCL can resemble various benign skin conditions, many patients are diagnosed at an advanced and difficult-to-treat stage. But ongoing clinical trials may offer patients with CTCL improved treatments and better quality of life.
• Swallowing Therapy Improves Function and Quality of Life for Patients with Head and Neck Cancer: In patients with head and neck cancer, loss of swallowing function may result from radiation therapy, surgery, or the cancer itself and …

Oncolog, Volume 61, Number 01, January 2016, Sarah Bronson, Bryan Tutt, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Proactive Management of Li-Fraumeni Syndrome Benefits Patients: Li-Fraumeni syndromes a hereditary disorder that confers an extremely high likelihood of developing cancer on affected individuals.
• Clinical Trial Tests High-Dose Radiation Therapy for Limited Stage Small Cell Lung Cancer: Small cell lung cancer carries a poor prognosis, even for patients without metastatic disease. But a phase III trial of high-dose daily or accelerated twice-daily thoracic radiation therapy for limited stage small cell kung cancer may lead to longer survival.
• Reducing Complications and Hospital Readmissions after Liver Surgery: Hepatectomy carries a risk of complications that can lead to hospital readmission and even death. …

Oncolog, Volume 60, Number 11 - 12, November - December 2015, Joe Munch, Bryan Tutt, C. Graber

OncoLog MD Anderson's Report to Physicians (All issues)

• Multidisciplinary Treatment Maximizes Outcomes for malignant Tumors of the Anterior Skull Base: Malignant tumors of the anterior skull base occur in a delicate area but often need aggressive treatment. Determining the best course of therapy for patients with these tumors takes a multidisciplinary effort.
• Management of Eyelid and Conjunctival Tumors with Preservation of Slight, Function and Cosmesis: Tumors of the eyelid and extent of disease, and which treatments, if any, are needed after surgical excision depends on several factors, including the potential for metastasis.
• HOUSE CALL: "Other" Health Risks from Smoking-Besides cancer, tobacco causes many diseases.

Oncolog, Volume 57, Number 04, April 2012, Joe Munch, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Biology, More Than Chemotherapy Timing, Drives Locoregional Recurrence in Patients Who Undergo Breast-Conserving Therapy: The management of breast cancer, like that of many cancers, often requires a little bit of everything: surgery, radiation therapy, and systemic therapy with chemotherapeutic drugs or other agents
• New Treatments for Acute Myelogenous Leukemia May Improve Patient Outcomes: Acute myelogenous leukemia (AML) is an aggressive and deadly malignancy, nut new treatments are being developed that may prolong remissions
• HOUSE CALL: Controlling Nausea and Vomiting from Chemotherapy: Several techniques can be used to prevent or reduce this side effect

Oncolog, Volume 57, Number 02, February 2012, Don Norwood, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Pediatric and Adult Cancer Patients Face Different Issues in Care, Survivorship: The challenges faced by children and adults with cancer can differ markedly, even when they have the same type of cancer
• Palliative Care May Offer Survival Benefits: Recent studies indicate that palliative care, which has been shown to improve quality of life in patients with advanced cancer, may also help patients live longer
• INBRIEF: Targeted Therapy Causes Chronic Lymphocytic Leukemia Remission/Study Finds Acupuncture Can Prevent Radiation-Induced Chronic Dry Mouth
• HOUSE CALL: Understanding the risks, benefits, and purpose of a trial can help cancer patients decide whether to participate

Oncolog, Volume 56, Number 06, June 2011, John H. Mccool, Sunni Hoseman

OncoLog MD Anderson's Report to Physicians (All issues)

• MD Anderson Celebrates 70th Anniversary: Its first clinical facility was a converted Army barracks, its first headquarters was renovated residential estate near downtown Houston, and its first cancer research was conducted by four scientists in a former horse stable
• Compass: Stage II or III Soft Tissue Sarcoma-Chemotherapy and radiation therapy before or after surgery benefit patients

Oncolog, Volume 56, Number 03, March 2011, Bryan Tutt, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues)

• Glioblastoma Cure Remains Elusive Despite Treatment Advances: Aggressive surgery followed by radiation therapy and chemo-therapy offers hope of long-term survival for some patients with glioblastoma, but for most glioblastoma patients, the prognosis is poor
• Assessing and Addressing the Biological Effects of Stress in Cancer Patients: Stress has long been linked to cancer progression. But the precise mechanisms by which stress exacts its pro-tumor effects are not fully understood
• MD Anderson One of Four Centers to Test Cancer Cell Detection Chip: A new test that could monitor the effectiveness of cancer treatment
• HOUSE CALL: Yoga and Tai Chi: Two distinct disciplines …

Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

• Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
• Screen Guidelines in Brief
• Electronic Navigation Biopsy for Peripheral Lung Lesion Diagnosis
• House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
• in Brief: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression

Oncolog Volume 55, Number 10, October 2010, Sunni Hoseman, Stephanie Deming

OncoLog MD Anderson's Report to Physicians (All issues)

• Protecting the Patient during Radiation Theraphy: Staff expertise and equipment accuracy are essential to safe and effective treatment
• Compass Fall 2010: Stage II Colon Cancer: Adjuvant Therapy? After Surgery, some patients benefit from chemotherapy
• HOUSE CALL: Managing Cancer-Related Pain
• INBRIEF: Researchers identify Enzyme Involved in Chemotherapy Resistance

Oncolog Volume 55, Number 04-05, April-May 2010, John Lebas, Sunni Hoseman

OncoLog MD Anderson's Report to Physicians (All issues)

• IMAGING NERVES: Tetnus Toxin Offers Promise for Neurography
• INBRIEF: Fight-or-Flight Hormones Linked to Metastasis/Drug Combination Shows Promise for Colon Cancer Chemoprevention
• Compass Spring 2010: Early Uterine Papillary Serous Carcinoma: Treatment Options Tailored to Patient and Disease Characteristcs
• House Call: Addressing the Cosmetic Effects of Breast Cancer

Oncolog Volume 55, Number 03, March 2010, Bryan Tutt, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues)

• Benign Tumors That Cause Big Problems:Fortunately, parathyroid tumors can be removed with minimally invasive surgery.
• Preventing Bone Loss nad Fractures in Cancer Patients
• INBRIEF: Leukemia Cells Observed Burning Fat to Evade Death/Assesment Tool Takes Aim at Graft-versus-Host Disease
• House call: Immunotherapy:Boosting the Body's Fight Against Cancer

Oncolog Volume 55, Number 01, January 2010, Bryan Tutt, Bita Esmaeli

OncoLog MD Anderson's Report to Physicians (All issues)

"

• Ocular Cancer: Tumors of the eye threaten sight and often indicate presence of extensive disease
• Eye Care for Cancer Patients
• Doctors Team Up to Battle Retinoblastoma
• Compass Winter 2010: Ductal Carcinoma In Situ: Choosing Treatment for a Common Group of Early, Confined Breast Cancers
• Toward Tomorrow
• House Call: Three Targets for New Year's Resolutions

"

Oncolog Volume 54, Number 11/12, November/December 2009, Dawn Chalaire, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues)

• Treating Neurofibromatosis
• Personalized Therapy for Lung Cancer
• House Call: Genetic Screening for Cancer Risks Gives Patients Options

Oncolog Volume 54, Number 04, April 2009, Sunita Patterson, Sunni Hosemann

OncoLog MD Anderson's Report to Physicians (All issues)

• Rebuilding What Cancer Has Ravaged
• Organ-Confined Prostate Cancer
• House Call: Integrative Medicine: Understanding Complementary and Alternative Therapies

Oncolog Volume 54, Number 03, March 2009, Joe Munch

OncoLog MD Anderson's Report to Physicians (All issues)

• Rare Tumors: Finding Common Ground
• Neuroendocrine Tumors
• House Call: How You Can Help a Seriously Ill Friend

Oncolog Volume 54, Number 02, February 2009, Maude Veech, Joe Munch, Don Norwood

OncoLog MD Anderson's Report to Physicians (All issues)

• Accelerated Partial Breast Irradiation: A Promising Adjuvant to Lumpectomy Acute Lymphoblastic Leukemia: Pediatric Regimens for Adolescents and
• House Call: Think About Your Medical Needs When Preparing for Natural Disasters
• Young Adults Yield Survival Advantages
• A New Biomarker for Bladder Cancer?

Oncolog Volume 54, Number 01, January 2009, John Lebas, Sunni Hosemann

OncoLog MD Anderson's Report to Physicians (All issues)

• Redefining Cancer Care
• Early-Stage Laryngeal Cancer
• House Call: Trouble Sleeping? Getting Help Can Improve Your Health

Oncolog Volume 53, Number 07/08, July/August 2008, John Lebas, Sunni Hosemann

OncoLog MD Anderson's Report to Physicians (All issues)

• Multiple Myeloma: Increasing Response, Remission, and Survival Rates in a Complex Disease
• House Call: A Guide to Radiation Therapy
• In Brief: Researchers Enhance Anticancer Activity of Natural Killer Cells in Laboratory
• Beyond Images: Advances in Interventional Radiology
• Radioembolotherapy Using Yttrium 90